Energy Alterations in Patients with Pulmonary Artery Thrombosis After COVID-19 Treatment

Introduction: There are some studies in the literature reporting cases of pulmonary thrombosis after treatment of acute phase of SARS-CoV-2 infection. Purpose: The purpose of this study is to show that patients that have pulmonary thrombosis has in the back ground prior to COVID-19, energy deficiency in the five internal massive organs, responsible for the production of energy necessary to keep the Blood flowing normally inside the Blood vessels. The treatment used nowadays to treat patient with SARS-CoV-2 infection can reduce even more this energy and can cause Blood stagnation inside the blood vessels in any part of the body, in this case, in the pulmonary vessels. Methods: Through one case report of 36 years-old female patient with history of SARS-CoV-2 infection on February 2nd 2021. In the beginning of her symptoms, she presented only runny nose and flu-like symptoms. She evolves to body pain and headache and in the third day, she tested positive to SARSCoV-2. It was prescribed Ivermectin and Azithromycin and she stayed 14 days isolated at home. On 16th day since the first manifestation, she returned to work and began to feel left chest pain. She did many exams to see if the Heart was compromised but nothing was found. There was only alteration in the pulmonary artery pressure and after it was diagnosed pulmonary thrombosis after performing Angio tomography. She started to use Rivaroxaban (Xarelto) and after this treatment, she improved and the symptoms disappeared but she is still using the medication until today. She went to my clinic in January 2022 to treat anxiety and she told me about all history of SARS-CoV-2 infection and complications. I performed to measurement of her internal massive organs through a crystal-pendulum using radiesthesia procedure. Results: what I found was a complete lack of energy inside the five internal massive organs (Liver, Heart, Spleen, Lungs, Kidney) responsible for the production of Yin, Yang, Qi and Blood to keep the blood flowing inside the blood vessels. Conclusion: The conclusion of this study is that patients with pulmonary artery thrombosis post COVID-19 symptoms can have energy deficiency inside the five internal massive organs and the use of highly concentrated medications to treat this condition and many other clinical conditions can worse more this reduction in energy and cause stagnation of Blood inside the blood vessels and cause in this case, pulmonary thrombosis.